EP 4359528 A1 20240501 - SIRNA COMBINATIONS TARGETING SARS-COV-2 AND/OR HOST FACTOR TRANSCRIPTS
Title (en)
SIRNA COMBINATIONS TARGETING SARS-COV-2 AND/OR HOST FACTOR TRANSCRIPTS
Title (de)
GEGEN SARS-COV-2- UND/ODER WIRTSFAKTORTRANSKRIPTE GERICHTETE SIRNA-KOMBINATIONEN
Title (fr)
COMBINAISONS D'ARNSI CIBLANT LES TRANSCRITS DU SRAS-COV-2 ET/OU DU FACTEUR HÔTE
Publication
Application
Priority
- EP 21181809 A 20210625
- EP 2022067506 W 20220627
Abstract (en)
[origin: WO2022269097A1] This invention relates to siRNA combinations targeting coronavirus (SARS-CoV-2) transcripts and/or host factor transcripts. The invention further relates to siRNA combinations and pharmaceutical compositions comprising said siRNA combinations for use in the treatment and prophylaxis of coronavirus infections, particularly coronavirus disease 2019.
IPC 8 full level
C12N 15/113 (2010.01)
CPC (source: EP)
C12N 15/1131 (2013.01); C12N 2310/14 (2013.01); C12N 2320/31 (2013.01); C12N 2330/31 (2013.01)
Citation (search report)
See references of WO 2022269097A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DOCDB simple family (application)
EP 2022067506 W 20220627; EP 22738426 A 20220627